Tracey Ashcraft

Executive Director, Financial Planning & Analysis at Poseida Therapeutics, Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Athena on Boards, Certified
    Athena
    Jan, 2020
    - Nov, 2024

Experience

    • United States
    • Biotechnology Research
    • 200 - 300 Employee
    • Executive Director, Financial Planning & Analysis
      • Nov 2020 - Present

    • Project Consultant
      • Feb 2020 - Nov 2020

      Implementation services for cloud based planning and forecasting EPM solution Planful (Host Analytics). Implementation services for cloud based planning and forecasting EPM solution Planful (Host Analytics).

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Senior Director, Financial Planning & Analysis
      • 2014 - Jan 2020

      Senior finance partner collaborating with C-suite, business unit, and project leaders to prepare detailed budgets and analyze trends for multiple business units, 45 departments, and 40 projects. • Prepared annual detailed, consolidated budgets and rolling forecasts, including balance sheets and cash flows, to support continuous monitoring of corporate cash burn and drive cost control measures throughout the organization. • Championed and led transition to an automated online solution (Planful), reducing turnaround time on forecast updates by several weeks and improving reporting cadence by one week. • Catalyzed culture shift to clearer financial management by leading initiative to improve R&D project leaders’ understanding of their project forecasts and financials. • Successfully handled multiple business unit and senior leadership reorganizations, including underlying project and department infrastructure modifications and allocation methodologies to reflect new matrixed financial management and reporting requirements. • Recognized as thought partner by CFO while stepping in to fill vacant VP Finance role. • Managed and mentored senior finance manager responsible for supporting synthetic biology platform unit and RNA medicine programs. • Coordinated composition of the financial package and presentation for quarterly board meetings and investor reporting; reviewed results with board members and high-profile investors. • Key partner on long-term plan used for periodic company valuations (409A).

    • Senior Director, Financial Planning & Analysis
      • 2006 - 2014

      Acted in senior advisory capacity to CEO, CFBO, SVP Finance and business unit GMs. Directed corporate-wide budget process and analyzed trends and metrics for 6 business units, 75+ departments (800 employees) during period of 5 acquisitions. • Recipient of Executive Management Award for Quality (2007). • Promoted as first woman to Senior Director level during period of 5 acquisitions and 400% employee growth; founding member of women’s leadership network. • Prepared first 5-year plan after purchase by the parent company used in tracking performance for equity plan valuation and impact of new initiatives for annual strategic planning process. • Decreased turnaround time on rolling forecasts by over a week while improving data integrity and automation of the consolidation process by advocating implementation of Cognos Planning budgeting software, including training end users. • Created distribution cost per shipment model to forecast and measure business performance and to drive decisions regarding capacity and future facility investment. • Organized creation of the financial package and presentation for quarterly financial reviews and board meetings. • Prepared and presented quarterly financials to employees at company meetings, enhancing effective corporate communication by sharing implications of results towards company goals.

    • Director, Operations Planning
      • 2002 - 2006

      Delivered operations and financial leadership for public drug discovery collaboration and services company with $50M in revenue and 6 acquisitions in 6 years. • Provided management with financial data to justify business decisions by producing detailed budget and standard monthly financial reporting for all worldwide business units within 2 months of hire. • Implemented online budgeting software within first 5 months of hire. • Established standard costing model used by the accounting group for overhead distribution, business development for proposal creation, and project managers for estimations. • Supported financial P&L project management and led reviews of research programs, including a multi-year $140M multi-project program.

    • Director, Research & Analysis
      • 1999 - 2002

      Provided executive-level financial strategy for public real estate database company with $220M in revenue and 8 acquisitions/mergers in 4 years. “Does What It Takes” Award (Employee of the Year). • Executed formal financial packages for creditor presentations resulting in over $20M in financing. • Prepared and analyzed financials and made recommendations on merger and acquisition prospects, closure of business units, and integration and consolidation opportunities. • Key team member identifying and implementing $5M (2000) and $12M (2001) annual cost savings.

    • Business Analyst
      • 1997 - 1999

      • Administered a $26M operating budget for 25 S,G&A, and R&D departments. • Administered a $26M operating budget for 25 S,G&A, and R&D departments.

Education

  • San Diego State University
    Master of Business Administration - MBA, Finance
  • University of California San Diego
    Bachelor of Arts - BA, Chemistry

Community

You need to have a working account to view this content. Click here to join now